{"id":4144,"date":"2011-12-21T18:20:00","date_gmt":"2011-12-21T23:20:00","guid":{"rendered":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/"},"modified":"2018-10-17T13:41:25","modified_gmt":"2018-10-17T17:41:25","slug":"potential-treatment-strategy-for-angelman-syndrome-identified","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/","title":{"rendered":"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth"},"content":{"rendered":"<div>\n<p class=\"lead\">December 2011 \u2013 Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.<\/p>\n<div class=\"image-section\">\n<figure class=\"thumbnail wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium size-full wp-image-4145\" src=\"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg\" alt=\"image2\" width=\"300\" height=\"200\"><figcaption class=\"caption wp-caption-text\">At top, a mouse brain showing flourescent expression of the UBE3A gene, and below, lack of expression when the maternal copy of the gene is missing.<\/figcaption><\/figure>\n<\/div>\n<div>\n<p><i>December 2011 <\/i>\u2013 An interdisciplinary team of UNC scientists say they have found a way to \u201cawaken\u201d the paternal allele of Ube3a, which could lead to a potential treatment strategy for Angelman syndrome (AS). Their results were published online by the journal Nature. <a class=\"external-link\" href=\"http:\/\/news.unchealthcare.org\/news\/2011\/december\/unc-study-could-lead-to-a-treatment-for-angelman-syndrome\">Read the complete UNC School of Medicine news release &gt;&gt;<\/a><\/p>\n<p><a class=\"external-link\" href=\"http:\/\/sfari.org\/news-and-opinion\/conference-news\/2011\/society-for-neuroscience-2011\/researchers-identify-drug-candidate-for-angelman-syndrome\">Simons Foundation Autism Research Institute news release &gt;&gt; <\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p><!-- description --> <\/p>\n<p class='lead'>December 2011 &#8211; Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.<\/p>\n","protected":false},"author":80868,"featured_media":4145,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[5,29],"featured-item":[],"class_list":["post-4144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-philpot-news","tag-zylka-news","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth - Department of Cell Biology and Physiology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth - Department of Cell Biology and Physiology\" \/>\n<meta property=\"og:description\" content=\"December 2011 - Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Cell Biology and Physiology\" \/>\n<meta property=\"article:published_time\" content=\"2011-12-21T23:20:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-17T17:41:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"227\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nathaniel Bailey\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nathaniel Bailey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/\"},\"author\":{\"name\":\"Nathaniel Bailey\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/5858263096b03dd1d401a4f6e847b994\"},\"headline\":\"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth\",\"datePublished\":\"2011-12-21T23:20:00+00:00\",\"dateModified\":\"2018-10-17T17:41:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/\"},\"wordCount\":122,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg\",\"keywords\":[\"Philpot news\",\"Zylka news\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/\",\"url\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/\",\"name\":\"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth - Department of Cell Biology and Physiology\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg\",\"datePublished\":\"2011-12-21T23:20:00+00:00\",\"dateModified\":\"2018-10-17T17:41:25+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/5858263096b03dd1d401a4f6e847b994\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg\",\"width\":227,\"height\":300,\"caption\":\"At top, a mouse brain showing flourescent expression of the UBE3A gene, and below, lack of expression when the maternal copy of the gene is missing.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/\",\"name\":\"Department of Cell Biology and Physiology\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/5858263096b03dd1d401a4f6e847b994\",\"name\":\"Nathaniel Bailey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1cc270581bd216cabc0f29913fe2581f219e2e9cf331ed4c50c22821a81d0208?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1cc270581bd216cabc0f29913fe2581f219e2e9cf331ed4c50c22821a81d0208?s=96&d=mm&r=g\",\"caption\":\"Nathaniel Bailey\"},\"url\":\"https:\/\/www.med.unc.edu\/cellbiophysio\/author\/nathaniel-bailey\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth - Department of Cell Biology and Physiology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/","og_locale":"en_US","og_type":"article","og_title":"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth - Department of Cell Biology and Physiology","og_description":"December 2011 - Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.","og_url":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/","og_site_name":"Department of Cell Biology and Physiology","article_published_time":"2011-12-21T23:20:00+00:00","article_modified_time":"2018-10-17T17:41:25+00:00","og_image":[{"width":227,"height":300,"url":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","type":"image\/jpeg"}],"author":"Nathaniel Bailey","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nathaniel Bailey","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/"},"author":{"name":"Nathaniel Bailey","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/5858263096b03dd1d401a4f6e847b994"},"headline":"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth","datePublished":"2011-12-21T23:20:00+00:00","dateModified":"2018-10-17T17:41:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/"},"wordCount":122,"image":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","keywords":["Philpot news","Zylka news"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/","url":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/","name":"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth - Department of Cell Biology and Physiology","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","datePublished":"2011-12-21T23:20:00+00:00","dateModified":"2018-10-17T17:41:25+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/5858263096b03dd1d401a4f6e847b994"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#primaryimage","url":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","contentUrl":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","width":227,"height":300,"caption":"At top, a mouse brain showing flourescent expression of the UBE3A gene, and below, lack of expression when the maternal copy of the gene is missing."},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/potential-treatment-strategy-for-angelman-syndrome-identified\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/cellbiophysio\/"},{"@type":"ListItem","position":2,"name":"Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/#website","url":"https:\/\/www.med.unc.edu\/cellbiophysio\/","name":"Department of Cell Biology and Physiology","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/cellbiophysio\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/5858263096b03dd1d401a4f6e847b994","name":"Nathaniel Bailey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/cellbiophysio\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1cc270581bd216cabc0f29913fe2581f219e2e9cf331ed4c50c22821a81d0208?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1cc270581bd216cabc0f29913fe2581f219e2e9cf331ed4c50c22821a81d0208?s=96&d=mm&r=g","caption":"Nathaniel Bailey"},"url":"https:\/\/www.med.unc.edu\/cellbiophysio\/author\/nathaniel-bailey\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","featured_image_medium":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","featured_image_large":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-content\/uploads\/sites\/734\/2018\/06\/potential-treatment-strategy-for-angelman-syndrome-identified-image2-150x150.jpeg","featured_image_alt":"At top, a mouse brain showing flourescent expression of the UBE3A gene, and below, lack of expression when the maternal copy of the gene is missing.","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/cellbiophysio\/category\/news\/"}],"tag_details":[{"name":"Philpot news","link":"https:\/\/www.med.unc.edu\/cellbiophysio\/tag\/philpot-news\/"},{"name":"Zylka news","link":"https:\/\/www.med.unc.edu\/cellbiophysio\/tag\/zylka-news\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/posts\/4144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/users\/80868"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/comments?post=4144"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/posts\/4144\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/media\/4145"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/media?parent=4144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/categories?post=4144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/tags?post=4144"},{"taxonomy":"featured-item","embeddable":true,"href":"https:\/\/www.med.unc.edu\/cellbiophysio\/wp-json\/wp\/v2\/featured-item?post=4144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}